SlideShare uma empresa Scribd logo
1 de 53
SMOKELESSTOBACCOAND Related
legislations
Presenter : Dr. WALIED K. BALWAN
Moderater: Dr. Abdul Majid Ganai (Prof and Head)
S/R incharge: Dr. FEROZ A. WANI
DEPARTMENT OF COMMUNITY MEDICINE,
SKIMS- SRINAGAR
Table of Contents;
 INTRODUCTION/ BURDEN
 SMOKELESS TOBACCO
 COMPONENTS
 EFFECTS OF SMOKELESS TOBACCO
 PREVENTION AND CONTROL
 LEGISLATIONS
INTRODUCTION
India has one of the highest rates of oral cancer in
the world.
Tobacco is responsible for a significant amount of
morbidity & mortality among middle aged adults.
Tobacco-related cancers - 1/2 of all cancers - men &
1/4 th among women.
Oral cancer - 1/3rd total cancer ; 90% - tobacco
chewers.
Men are affected 2-3 times than women due to
higher use of alcohol & tobacco .
 Tongue & intra-oral cancer - equal in both as
chewing tobacco among women is common.
 Effects of tobacco use, heavy alcohol consumption ,
and poor diet together explain over 90% of head &
neck cancers.
 According to WHO’s Mortality Attributable to
Tobacco Report, globally 12% of all deaths
among adults aged 30 years and above were
due to smokeless tobacco in compared with
16% in India, Pakistan (17%)
and Bangladesh (31%).
 According to GATS 33% of adults use tobacco
in some form , and prevalence of smokeless
tobacco use 26%
 According to GYTS 13.6% school going
children out of which 9% were using
smokeless tobacco
What Is Smokeless
Tobacco?
Smokeless tobacco / spit tobacco / chewing
tobacco.
Mainly two forms: snuff and chewing
tobacco.
Snuff - users "pinch" or "dip" between their
lower lip and gum.
Chewing tobacco - users put between their
cheek and gum.
 The tobacco juice is sucked and chewed -
nicotine -absorbed into the bloodstream
through the oral tissues.
 No need to swallow
Consumption
Chewed : gutkha, pan, mawa,
mainpuri tobacco, khaini, zarda
Applied on gums and teeth : mishri,
gudhaku, bajjar, tooth paste
Inhaled : snuff.
gutkhA
Leads to Oral sub-mucous fibrosis (SMF).
Main component - arecanut along with tobacco.
KHAINI
 Paste of tobacco + slaked lime & is used with
arecanut.
 Mixed with the thumb to make the mixture alkaline-
premolar region of mandibular groove
MAINPURI TOBACCO
Tobacco+ slaked lime + finely cut arecanut +
camphor + cloves.
Mainly-Uttar Pradesh.
High incidence of oral cancer & leukoplakia.
MAWA
Gujarati preparation made from shavings
of arecanut, tobacco and slaked lime.
 Sold by tobacco vendors in cellophane
papers tied like a small ball.
SNUFF
Finely powdered air-cured & fire-cured
tobacco leaves.
Used orally/nasally.
Carried in a metal container-a twig is
dipped into it-placed in oral vestibule.
Causes oral squamous cell carcinoma.
ZARDA
Tobacco leaves + lime+spices – boiled in
water.
Residual tobacco –dried & coloured.
Oral cancer, Oral submucosis fibrosis
Cracking & bleeding lips & gums.
Receding gums –tooth falls out.
 Increased heart rate, high B.P, irregular
heartbeats - greater risk of heart attacks.
 Can lead to nicotine addiction.
 Can increase risks for early delivery and
stillbirth when used during pregnancy.
 Can cause nicotine poisoning in children.
EFFECTS OF SMOKELESS TOBACCO
Why do people Use Tobacco?
 This may depend on social class and
local factors, some of which are :
1. Peer influence and pressure
2. Advertisements/promotions of tobacco
products through films, free distribution,
sponsorships, etc
3. Curiosity and experimentation.
4. Fun and enjoyment
5. A challenge, a sign of rebellion.
6. Relief of Negative feelings like stress,
anxiety, boredom.
Prevention and Control
Levels of Prevention
Disease prevention in tobacco users
always involves informing users about
the health risks the face and
promoting cessation of tobacco use.
PRIMORDIAL PREVENTION to
prevent initiation of tobacco use;
1. To be provided in the community and
the clinic.
2. Health education especially at school
level.
PRIMARY PREVENTION to help
tobacco users quit
1. To be provided at clinics
2. Tobacco cessation services for
tobacco users who haven’t yet
exhibited any disease.
SECONDARY PREVENTION
for early diagnosis and treatment of
diseases in tobacco users.(
screening for oral cancer and pre
cancerous lesions).
TERTIARY PREVENTION
 To help heavy users quit, many of
whom have tobacco related symptoms
and diseases.
 Has to be done in special clinics or
hospitals.
 Treatment for heavy users.
Why Intervene?
 The intervention by health care
professional, can help motivate
patients to change their behavior.;
 Intervention helps them to think about
the importance of quitting tobacco use
because of the authority and standing
the health care professional enjoys in
society.
 Physicians are viewed not only as
clinicians, but also educator and role
models.
Behaviour Counselling for
Tobacco cessation (5 ‘A’s)
1. Ask- Ask the patient if he/she is a
tobacco user, at every visit.
2. Advise- Briefly advise against
continuing tobacco use and link the
current condition/ ailment to
continued tobacco use.
3. Asses- Asses readiness to quit by
asking the patient whether he/she is
ready to quit (eg. ‘ How recently you
have thought of quitting tobacco’)
If the patient appears ready to
change( quit),
1 Assist; Assist the tobacco users in
making a quit.
2 Arrange; Arrange for follow up by
setting the next contact.
Approach for a current tobacco
users who is not quitting tobacco
use (5 ‘R’s)
1. Relevance- Explain the relevance of
quitting to the client and harmful
effects of tobacco use.
2. Risks- Highlight the health hazards
that are more relevant to the
individual tobacco user.
3. Rewards- Benefits of quitting all
forms of tobacco use should be
explained
( Health ,financial, approval of family
etc.)
4. Roadblocks- Barriers that the client
may face in his/her quit attempt should
be identified. Withdrawal symptoms,
fears and concern associated with
quitting, depression, lack of social
support, enjoyment of tobacco are some
of barriers that the client may face in
attempt.
5. Repetition- The physician should
assure the client that because of
chronic nature of tobacco
dependence, relapses are common in
the initial phases and multiple
attempts may have to be made before
he/she is able to quit tobacco.
WHO INITIATIVE
WHO-FCTC
 The World Health Organization
Framework Convention on Tobacco
Control (WHO FCTC) is a treaty adopted by
the 56th World Health Assembly on 21 May
2003. It became the first World Health
Organization treaty adopted under article 19
of the WHO constitution. The treaty came
into force on 27 February 2005.It had been
signed by 168 countries and is legally
binding in 180 ratifying countries.
 It is an evidence based treaty that reaffirms
the right of all people to the highest standard
of health.
MPOWER PACKAGE
 MPOWER is a policy package intended to
assist in the country-level implementation of
effective interventions to reduce the demand for
tobacco, as ratified by the World Health
Organization (WHO) Framework Convention on
Tobacco Control .The six evidence-based
components of MPOWER are:
 Monitor tobacco use and prevention policies
 Protect people from tobacco smoke
 Offer help to quit tobacco use
 Warn about the dangers of tobacco
 Enforce bans on tobacco advertising, promotion
and sponsorship
 Raise taxes on tobacco
 Reduce the size of cigarette
TOBACCO CONTROL IN INDIA
In order to discourage tobacco use and protect
the youth and masses from harmful effect of
tobacco use and SHS , GOI enacted
COTPA
Cigarettes and Other tobacco products (Prohibition of Advertisement
and Regulation of Trade and Commerce, Production, Supply and
Distribution) Act, 2003
SCOPE OF ACT:
 The Act is applicable to all products containing tobacco in any form i.e.
cigarettes, cigars, cheroots, bidis, gutka, pan masala (containing
tobacco) khaini, mawa, mishri, snuff etc. as detailed in the schedule to
the Act.
 The Act extends to whole of India.
MAIN PROVISIONS OF THE
ACT
Enforcement agencies and
mechanisms
 Any police officer, not below the rank of Sub-
Inspector
 Any officer of State Food or Drug
Administration
 Any other officer, holding the equivalent rank
being not below the rank of Sub-Inspector of
Police
 Any other Official as authorized by the
Central/State Governments.
NATIONAL TOBACCO CONTROL PROGRAMME
The GOI launched NTCP in the 11th five
year plan (2007-12) to implement
Tobacco control Laws and bring about
greater awareness about ill effects of
tobacco, institute a regulatory
mechanism including laboratory facility
for effective monitoring and
implementation of Anti tobacco initiatives
at State/ District level.
Main Components
National Level:
Public awareness/ mass media campaigns
for awareness building and for
behavioural change.
Establishment of tobacco products testing
labs, to build regulatory capacity, as
required under COTPA,2003.
Mainstreaming researchs and programme
components as a part of health delivery
mechanism under NHM.
 Monitoring and evaluation including
surveillance (GATS/GYTS).
 Dedicate tobacco control cell for
effective implementation and
monitoring of Tobacco control
initiatives at state level.
STATE LEVEL
Dedicated tobacco control cell for
effective implementation of Tobacco
Control initiatives at state level.
DISTRICT LEVEL
Dedicated tobacco control cell for
effective implementation of Tobacco
Control initiatives at District level.
Training;
Training of school teachers, health
workers, health professionals, law
enforces, NGO’s, Women SHG’s on
tobacco control in the districts.
IEC:
Using local media, Nukkad/street corner
shows, Exhibition, Melas, etc in regional
languages at the grass root level.
School Programme:
As part of school health programme of
the state govt. or with the help of NGOs
to train school teachers and sensitize
children on harmful effects of tobacco,
SHS and provisions under the law, 50
schools are covered in each district.
Tobacco Cessation Centres (TCC):
Setting up of Tobacco Cessation
facilities at the District Hospital level.
National Tobacco Control Cell
 The NTCC is responsible for overall
policy formulation, planning, monitoring
and evaluation of the different activities
envisaged under the programme.
National cell functions
Joint Sec/Director and technical
support is provided by DGHS( i.e.
DDG/CMO.
Organizations (NTCC)
Training:
STCC should train multiple stake holders
of tobacco control level advocacy
workshops/senitization programmes.
Efforts should be made to involve all
state government department for
tobacco control. Specific tailors made
trainings should be organised for
academicians, Health
medical/professionals, students, police,
food and drug safety authorities,
judiciary, Media etc.
NTCP at District Level
 Every identified district should have
District Tobacco Control Cell (DTCC) in
the District Hospital.
 The DTCC is headed by DNO preferably
CMO/CS on full time basis.
 It is desirable that the DNO under NTCP
is also given the responsibility to look
after the NCD programmes like
NPCDCS, NMHP, NPHCE.Other team
members of this cell include
Psychologist/Counsellor, Social worker
and Data Entry Operator on contractual
basis under NTCP.
Target Trainees:
 Doctors, Nurses, Community Health
Workers, ASHAs, Civil society
Organisations, NCC, IMA, IDA,
Teachers, Officials from Enforcement
deptt. Like Police, Food Authorities,
Municipal Officers etc.
 Block Level Interventions:
Block level coordination committee;
Block chairperson, members of block
panchayat and gram pradhans (village
Heads), prominenet NGOs, CBOs ,local
MLAs,MPs,
Incharge MO of the Block PHC as convener.
Block level activities; orientation and
senitization of representatives, working
towards tobacco free schools and offices
in block.
Village level interventions:
 Village Level committee; village
Pradhan, ASHA,ANM, Anganwadi
worker , the meetings need to be
conevened by the ASHA worker.
 Village level activities; senitization of
village level officials, Gram Panchayat,
CBOs like Farmers clubs, Mothers
froups, SHGs, Youth/ Adolescent club
etc . Special IEC compaign involving
school children on World No Tobacco
Day, and special days.
What Further?
 Integration of NTCP with other health
interventions/programmes.
 As we are very well aware that
tobacco is a risk factor for cancer of
various organs,CVS and Pulmonary
diseases, and is strongly assoiciated
with it. Moreover also strong
association with pregnacy n
consequences.
Conclusions
 There are numbers of programme for
diseases control ,all efforts must be
made to integrate NTCP activities into
the ongoing National Health
programmes like RNTCP, NMHP.
NPCB, NPDCS, RCH etc.
Smokeless tobacco and cotpa

Mais conteúdo relacionado

Mais procurados

Tobacco smoking & oral cancer
Tobacco smoking & oral cancerTobacco smoking & oral cancer
Tobacco smoking & oral cancer
Fa Nasir
 
Presentation _ tobacco_control_edited_copy_final_17102016_d dutta
Presentation _ tobacco_control_edited_copy_final_17102016_d duttaPresentation _ tobacco_control_edited_copy_final_17102016_d dutta
Presentation _ tobacco_control_edited_copy_final_17102016_d dutta
drdduttaM
 
Oral Health Education and Health Promotion
Oral Health Education and Health PromotionOral Health Education and Health Promotion
Oral Health Education and Health Promotion
Ankit Mishra
 
Pregnancy And Your Oral Health
Pregnancy And Your Oral HealthPregnancy And Your Oral Health
Pregnancy And Your Oral Health
shabeel pn
 

Mais procurados (20)

Oral cancer
Oral cancer Oral cancer
Oral cancer
 
Anti tobacco counceling
Anti tobacco councelingAnti tobacco counceling
Anti tobacco counceling
 
Methods of tobacco cessation
Methods of tobacco cessationMethods of tobacco cessation
Methods of tobacco cessation
 
Smokeless Tobacco
Smokeless TobaccoSmokeless Tobacco
Smokeless Tobacco
 
Tobacco smoking and its bad effects
Tobacco smoking and its bad effectsTobacco smoking and its bad effects
Tobacco smoking and its bad effects
 
Risk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancerRisk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancer
 
Tobacco smoking & oral cancer
Tobacco smoking & oral cancerTobacco smoking & oral cancer
Tobacco smoking & oral cancer
 
Presentation _ tobacco_control_edited_copy_final_17102016_d dutta
Presentation _ tobacco_control_edited_copy_final_17102016_d duttaPresentation _ tobacco_control_edited_copy_final_17102016_d dutta
Presentation _ tobacco_control_edited_copy_final_17102016_d dutta
 
Harmful Health Effects of Tobacco consumption
Harmful Health Effects of Tobacco consumptionHarmful Health Effects of Tobacco consumption
Harmful Health Effects of Tobacco consumption
 
Management of Tobacco Use
Management of Tobacco UseManagement of Tobacco Use
Management of Tobacco Use
 
Oral Health Education and Health Promotion
Oral Health Education and Health PromotionOral Health Education and Health Promotion
Oral Health Education and Health Promotion
 
Oral cancer
Oral cancerOral cancer
Oral cancer
 
NICOTINE REPLACEMENT THERAPY
NICOTINE REPLACEMENT THERAPYNICOTINE REPLACEMENT THERAPY
NICOTINE REPLACEMENT THERAPY
 
Tobacco awareness ppt - smoking ppt
Tobacco awareness ppt - smoking pptTobacco awareness ppt - smoking ppt
Tobacco awareness ppt - smoking ppt
 
Tobacco cessation legislations in india
Tobacco cessation legislations in indiaTobacco cessation legislations in india
Tobacco cessation legislations in india
 
Effects of Tobacco on Health
Effects of Tobacco on HealthEffects of Tobacco on Health
Effects of Tobacco on Health
 
DENTIST act OF india
DENTIST act OF indiaDENTIST act OF india
DENTIST act OF india
 
How Tobacco Adversely Affects Oral Health
How Tobacco Adversely Affects Oral HealthHow Tobacco Adversely Affects Oral Health
How Tobacco Adversely Affects Oral Health
 
Epidemiology of oral cancer
Epidemiology of oral cancerEpidemiology of oral cancer
Epidemiology of oral cancer
 
Pregnancy And Your Oral Health
Pregnancy And Your Oral HealthPregnancy And Your Oral Health
Pregnancy And Your Oral Health
 

Destaque

National tobacco control program (ntcp)
National tobacco control program (ntcp)National tobacco control program (ntcp)
National tobacco control program (ntcp)
sarahg326
 
Tobacco Consumption between 18-24 (2005)
Tobacco Consumption between 18-24 (2005)Tobacco Consumption between 18-24 (2005)
Tobacco Consumption between 18-24 (2005)
Elizabeth E. Brait
 
How tobacco eats u
How tobacco eats uHow tobacco eats u
How tobacco eats u
Anita Saxena
 
Nicotine presentation
Nicotine presentationNicotine presentation
Nicotine presentation
Afsana Khan
 
Tobacco Powerpoint
Tobacco PowerpointTobacco Powerpoint
Tobacco Powerpoint
devil_2113
 
Oral cancer pwr.pnt.
Oral cancer pwr.pnt.Oral cancer pwr.pnt.
Oral cancer pwr.pnt.
kamalaiims
 

Destaque (18)

Dr. Ebbert Spit Tobacco Presentation
Dr. Ebbert Spit Tobacco PresentationDr. Ebbert Spit Tobacco Presentation
Dr. Ebbert Spit Tobacco Presentation
 
National tobacco control program (ntcp)
National tobacco control program (ntcp)National tobacco control program (ntcp)
National tobacco control program (ntcp)
 
Tobacco/Nicotine presentation
Tobacco/Nicotine presentation Tobacco/Nicotine presentation
Tobacco/Nicotine presentation
 
Cotpa 03
Cotpa 03Cotpa 03
Cotpa 03
 
LAAMPP Policy Webinar - Jeannette Noltenius
LAAMPP Policy Webinar - Jeannette NolteniusLAAMPP Policy Webinar - Jeannette Noltenius
LAAMPP Policy Webinar - Jeannette Noltenius
 
National Tobacco Control Strategy (NTCS)
National Tobacco Control Strategy (NTCS)National Tobacco Control Strategy (NTCS)
National Tobacco Control Strategy (NTCS)
 
Tobacco Consumption between 18-24 (2005)
Tobacco Consumption between 18-24 (2005)Tobacco Consumption between 18-24 (2005)
Tobacco Consumption between 18-24 (2005)
 
Control of tobacco products act
Control of tobacco products actControl of tobacco products act
Control of tobacco products act
 
How tobacco eats u
How tobacco eats uHow tobacco eats u
How tobacco eats u
 
Drugs and alcohol
Drugs and alcoholDrugs and alcohol
Drugs and alcohol
 
Anti-Tobacco Project
Anti-Tobacco ProjectAnti-Tobacco Project
Anti-Tobacco Project
 
Nicotine addiction
Nicotine addictionNicotine addiction
Nicotine addiction
 
Nicotine presentation
Nicotine presentationNicotine presentation
Nicotine presentation
 
Federal tobacco control
Federal tobacco controlFederal tobacco control
Federal tobacco control
 
Tobacco Powerpoint
Tobacco PowerpointTobacco Powerpoint
Tobacco Powerpoint
 
Oral cancer pwr.pnt.
Oral cancer pwr.pnt.Oral cancer pwr.pnt.
Oral cancer pwr.pnt.
 
Nur512 tobacco prevention and control (1)
Nur512 tobacco prevention and control (1)Nur512 tobacco prevention and control (1)
Nur512 tobacco prevention and control (1)
 
Gateway
GatewayGateway
Gateway
 

Semelhante a Smokeless tobacco and cotpa

14 01 16 Birmingham City Council presentation
14 01 16 Birmingham City Council presentation14 01 16 Birmingham City Council presentation
14 01 16 Birmingham City Council presentation
Kal Uba Ifegwu
 
SMOKING CESSATION _ CODP 8
SMOKING CESSATION _ CODP 8SMOKING CESSATION _ CODP 8
SMOKING CESSATION _ CODP 8
SoM
 
Who And Sfe
Who And SfeWho And Sfe
Who And Sfe
PRN USM
 

Semelhante a Smokeless tobacco and cotpa (20)

Workshop2 r.khoury
Workshop2 r.khouryWorkshop2 r.khoury
Workshop2 r.khoury
 
Management Of Stable Copd
Management Of Stable CopdManagement Of Stable Copd
Management Of Stable Copd
 
Smoking
SmokingSmoking
Smoking
 
Tobacco control
Tobacco controlTobacco control
Tobacco control
 
EPIDEMIOLOGY OF ORAL CANCER.pptx
EPIDEMIOLOGY OF ORAL CANCER.pptxEPIDEMIOLOGY OF ORAL CANCER.pptx
EPIDEMIOLOGY OF ORAL CANCER.pptx
 
14 01 16 Birmingham City Council presentation
14 01 16 Birmingham City Council presentation14 01 16 Birmingham City Council presentation
14 01 16 Birmingham City Council presentation
 
EPIDEMIOLOGY OF ORAL CANCER
EPIDEMIOLOGY OF ORAL CANCEREPIDEMIOLOGY OF ORAL CANCER
EPIDEMIOLOGY OF ORAL CANCER
 
SMOKING CESSATION _ CODP 8
SMOKING CESSATION _ CODP 8SMOKING CESSATION _ CODP 8
SMOKING CESSATION _ CODP 8
 
Smoking cesseation
Smoking cesseationSmoking cesseation
Smoking cesseation
 
World No Tobacco Day 2010
World No Tobacco Day 2010World No Tobacco Day 2010
World No Tobacco Day 2010
 
Who And Sfe
Who And SfeWho And Sfe
Who And Sfe
 
prevalence_of_oral_mucosal_lesions_among_smokeless.18 (1).pdf
prevalence_of_oral_mucosal_lesions_among_smokeless.18 (1).pdfprevalence_of_oral_mucosal_lesions_among_smokeless.18 (1).pdf
prevalence_of_oral_mucosal_lesions_among_smokeless.18 (1).pdf
 
Smoking patient education
Smoking patient educationSmoking patient education
Smoking patient education
 
Health-care interventions to promote and assist tobacco cessation: a review o...
Health-care interventions to promote and assist tobacco cessation: a review o...Health-care interventions to promote and assist tobacco cessation: a review o...
Health-care interventions to promote and assist tobacco cessation: a review o...
 
Srabana zonal
Srabana zonalSrabana zonal
Srabana zonal
 
218571848 50611339-tobacco-case-study
218571848 50611339-tobacco-case-study218571848 50611339-tobacco-case-study
218571848 50611339-tobacco-case-study
 
Wc to h_programme_06b
Wc to h_programme_06bWc to h_programme_06b
Wc to h_programme_06b
 
Program, plan, policy, strategies and SWOT analysis of COPD in Nepal
Program, plan, policy, strategies and SWOT analysis  of COPD in Nepal Program, plan, policy, strategies and SWOT analysis  of COPD in Nepal
Program, plan, policy, strategies and SWOT analysis of COPD in Nepal
 
Australian smoking cessation conference 2013
Australian smoking cessation conference 2013Australian smoking cessation conference 2013
Australian smoking cessation conference 2013
 
Hooked for Life – How Big Tobacco Companies Seduce Youth
Hooked for Life – How Big Tobacco Companies Seduce YouthHooked for Life – How Big Tobacco Companies Seduce Youth
Hooked for Life – How Big Tobacco Companies Seduce Youth
 

Mais de Wal

Mais de Wal (9)

Metrological Environment.pptx
Metrological Environment.pptxMetrological Environment.pptx
Metrological Environment.pptx
 
Newer vaccine new ppt
Newer vaccine new pptNewer vaccine new ppt
Newer vaccine new ppt
 
Hospital infection control guidelines
Hospital infection control guidelinesHospital infection control guidelines
Hospital infection control guidelines
 
Welfare schemes for women in india (1) copy
Welfare schemes for women in india (1)   copyWelfare schemes for women in india (1)   copy
Welfare schemes for women in india (1) copy
 
Nsp draft 20.02.2017 1
Nsp draft 20.02.2017 1Nsp draft 20.02.2017 1
Nsp draft 20.02.2017 1
 
Influenza
InfluenzaInfluenza
Influenza
 
Rntcp and national strategic plan(nsp) for tb
Rntcp and national strategic plan(nsp) for tbRntcp and national strategic plan(nsp) for tb
Rntcp and national strategic plan(nsp) for tb
 
Diarrhoea case presentation
Diarrhoea case presentationDiarrhoea case presentation
Diarrhoea case presentation
 
Zika virus
Zika virusZika virus
Zika virus
 

Último

In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait CityIn Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
Abortion pills in Kuwait Cytotec pills in Kuwait
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
ocean4396
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 

Último (20)

TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait CityIn Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
 
Evidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapyEvidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapy
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...
Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...
Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...
 
VVIP Yelahanka ℂall Girls 6350482085 Heat-immolating { Bangalore } Coveted Gi...
VVIP Yelahanka ℂall Girls 6350482085 Heat-immolating { Bangalore } Coveted Gi...VVIP Yelahanka ℂall Girls 6350482085 Heat-immolating { Bangalore } Coveted Gi...
VVIP Yelahanka ℂall Girls 6350482085 Heat-immolating { Bangalore } Coveted Gi...
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
 

Smokeless tobacco and cotpa

  • 1. SMOKELESSTOBACCOAND Related legislations Presenter : Dr. WALIED K. BALWAN Moderater: Dr. Abdul Majid Ganai (Prof and Head) S/R incharge: Dr. FEROZ A. WANI DEPARTMENT OF COMMUNITY MEDICINE, SKIMS- SRINAGAR
  • 2. Table of Contents;  INTRODUCTION/ BURDEN  SMOKELESS TOBACCO  COMPONENTS  EFFECTS OF SMOKELESS TOBACCO  PREVENTION AND CONTROL  LEGISLATIONS
  • 3. INTRODUCTION India has one of the highest rates of oral cancer in the world. Tobacco is responsible for a significant amount of morbidity & mortality among middle aged adults. Tobacco-related cancers - 1/2 of all cancers - men & 1/4 th among women. Oral cancer - 1/3rd total cancer ; 90% - tobacco chewers. Men are affected 2-3 times than women due to higher use of alcohol & tobacco .  Tongue & intra-oral cancer - equal in both as chewing tobacco among women is common.  Effects of tobacco use, heavy alcohol consumption , and poor diet together explain over 90% of head & neck cancers.
  • 4.  According to WHO’s Mortality Attributable to Tobacco Report, globally 12% of all deaths among adults aged 30 years and above were due to smokeless tobacco in compared with 16% in India, Pakistan (17%) and Bangladesh (31%).  According to GATS 33% of adults use tobacco in some form , and prevalence of smokeless tobacco use 26%  According to GYTS 13.6% school going children out of which 9% were using smokeless tobacco
  • 5. What Is Smokeless Tobacco? Smokeless tobacco / spit tobacco / chewing tobacco. Mainly two forms: snuff and chewing tobacco. Snuff - users "pinch" or "dip" between their lower lip and gum. Chewing tobacco - users put between their cheek and gum.  The tobacco juice is sucked and chewed - nicotine -absorbed into the bloodstream through the oral tissues.  No need to swallow
  • 6. Consumption Chewed : gutkha, pan, mawa, mainpuri tobacco, khaini, zarda Applied on gums and teeth : mishri, gudhaku, bajjar, tooth paste Inhaled : snuff.
  • 7. gutkhA Leads to Oral sub-mucous fibrosis (SMF). Main component - arecanut along with tobacco. KHAINI  Paste of tobacco + slaked lime & is used with arecanut.  Mixed with the thumb to make the mixture alkaline- premolar region of mandibular groove
  • 8. MAINPURI TOBACCO Tobacco+ slaked lime + finely cut arecanut + camphor + cloves. Mainly-Uttar Pradesh. High incidence of oral cancer & leukoplakia. MAWA Gujarati preparation made from shavings of arecanut, tobacco and slaked lime.  Sold by tobacco vendors in cellophane papers tied like a small ball.
  • 9. SNUFF Finely powdered air-cured & fire-cured tobacco leaves. Used orally/nasally. Carried in a metal container-a twig is dipped into it-placed in oral vestibule. Causes oral squamous cell carcinoma. ZARDA Tobacco leaves + lime+spices – boiled in water. Residual tobacco –dried & coloured.
  • 10. Oral cancer, Oral submucosis fibrosis Cracking & bleeding lips & gums. Receding gums –tooth falls out.  Increased heart rate, high B.P, irregular heartbeats - greater risk of heart attacks.  Can lead to nicotine addiction.  Can increase risks for early delivery and stillbirth when used during pregnancy.  Can cause nicotine poisoning in children. EFFECTS OF SMOKELESS TOBACCO
  • 11. Why do people Use Tobacco?  This may depend on social class and local factors, some of which are : 1. Peer influence and pressure 2. Advertisements/promotions of tobacco products through films, free distribution, sponsorships, etc 3. Curiosity and experimentation. 4. Fun and enjoyment 5. A challenge, a sign of rebellion. 6. Relief of Negative feelings like stress, anxiety, boredom.
  • 12. Prevention and Control Levels of Prevention Disease prevention in tobacco users always involves informing users about the health risks the face and promoting cessation of tobacco use. PRIMORDIAL PREVENTION to prevent initiation of tobacco use; 1. To be provided in the community and the clinic. 2. Health education especially at school level.
  • 13. PRIMARY PREVENTION to help tobacco users quit 1. To be provided at clinics 2. Tobacco cessation services for tobacco users who haven’t yet exhibited any disease. SECONDARY PREVENTION for early diagnosis and treatment of diseases in tobacco users.( screening for oral cancer and pre cancerous lesions).
  • 14. TERTIARY PREVENTION  To help heavy users quit, many of whom have tobacco related symptoms and diseases.  Has to be done in special clinics or hospitals.  Treatment for heavy users.
  • 15. Why Intervene?  The intervention by health care professional, can help motivate patients to change their behavior.;  Intervention helps them to think about the importance of quitting tobacco use because of the authority and standing the health care professional enjoys in society.  Physicians are viewed not only as clinicians, but also educator and role models.
  • 16. Behaviour Counselling for Tobacco cessation (5 ‘A’s) 1. Ask- Ask the patient if he/she is a tobacco user, at every visit. 2. Advise- Briefly advise against continuing tobacco use and link the current condition/ ailment to continued tobacco use. 3. Asses- Asses readiness to quit by asking the patient whether he/she is ready to quit (eg. ‘ How recently you have thought of quitting tobacco’)
  • 17. If the patient appears ready to change( quit), 1 Assist; Assist the tobacco users in making a quit. 2 Arrange; Arrange for follow up by setting the next contact.
  • 18. Approach for a current tobacco users who is not quitting tobacco use (5 ‘R’s) 1. Relevance- Explain the relevance of quitting to the client and harmful effects of tobacco use. 2. Risks- Highlight the health hazards that are more relevant to the individual tobacco user. 3. Rewards- Benefits of quitting all forms of tobacco use should be explained ( Health ,financial, approval of family etc.)
  • 19. 4. Roadblocks- Barriers that the client may face in his/her quit attempt should be identified. Withdrawal symptoms, fears and concern associated with quitting, depression, lack of social support, enjoyment of tobacco are some of barriers that the client may face in attempt.
  • 20. 5. Repetition- The physician should assure the client that because of chronic nature of tobacco dependence, relapses are common in the initial phases and multiple attempts may have to be made before he/she is able to quit tobacco.
  • 21.
  • 22.
  • 24. WHO-FCTC  The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) is a treaty adopted by the 56th World Health Assembly on 21 May 2003. It became the first World Health Organization treaty adopted under article 19 of the WHO constitution. The treaty came into force on 27 February 2005.It had been signed by 168 countries and is legally binding in 180 ratifying countries.  It is an evidence based treaty that reaffirms the right of all people to the highest standard of health.
  • 25.
  • 26.
  • 27. MPOWER PACKAGE  MPOWER is a policy package intended to assist in the country-level implementation of effective interventions to reduce the demand for tobacco, as ratified by the World Health Organization (WHO) Framework Convention on Tobacco Control .The six evidence-based components of MPOWER are:  Monitor tobacco use and prevention policies  Protect people from tobacco smoke  Offer help to quit tobacco use  Warn about the dangers of tobacco  Enforce bans on tobacco advertising, promotion and sponsorship  Raise taxes on tobacco  Reduce the size of cigarette
  • 28. TOBACCO CONTROL IN INDIA In order to discourage tobacco use and protect the youth and masses from harmful effect of tobacco use and SHS , GOI enacted COTPA Cigarettes and Other tobacco products (Prohibition of Advertisement and Regulation of Trade and Commerce, Production, Supply and Distribution) Act, 2003 SCOPE OF ACT:  The Act is applicable to all products containing tobacco in any form i.e. cigarettes, cigars, cheroots, bidis, gutka, pan masala (containing tobacco) khaini, mawa, mishri, snuff etc. as detailed in the schedule to the Act.  The Act extends to whole of India.
  • 30. Enforcement agencies and mechanisms  Any police officer, not below the rank of Sub- Inspector  Any officer of State Food or Drug Administration  Any other officer, holding the equivalent rank being not below the rank of Sub-Inspector of Police  Any other Official as authorized by the Central/State Governments.
  • 31. NATIONAL TOBACCO CONTROL PROGRAMME The GOI launched NTCP in the 11th five year plan (2007-12) to implement Tobacco control Laws and bring about greater awareness about ill effects of tobacco, institute a regulatory mechanism including laboratory facility for effective monitoring and implementation of Anti tobacco initiatives at State/ District level.
  • 32. Main Components National Level: Public awareness/ mass media campaigns for awareness building and for behavioural change. Establishment of tobacco products testing labs, to build regulatory capacity, as required under COTPA,2003. Mainstreaming researchs and programme components as a part of health delivery mechanism under NHM.
  • 33.  Monitoring and evaluation including surveillance (GATS/GYTS).  Dedicate tobacco control cell for effective implementation and monitoring of Tobacco control initiatives at state level.
  • 34. STATE LEVEL Dedicated tobacco control cell for effective implementation of Tobacco Control initiatives at state level. DISTRICT LEVEL Dedicated tobacco control cell for effective implementation of Tobacco Control initiatives at District level.
  • 35. Training; Training of school teachers, health workers, health professionals, law enforces, NGO’s, Women SHG’s on tobacco control in the districts. IEC: Using local media, Nukkad/street corner shows, Exhibition, Melas, etc in regional languages at the grass root level.
  • 36. School Programme: As part of school health programme of the state govt. or with the help of NGOs to train school teachers and sensitize children on harmful effects of tobacco, SHS and provisions under the law, 50 schools are covered in each district. Tobacco Cessation Centres (TCC): Setting up of Tobacco Cessation facilities at the District Hospital level.
  • 37.
  • 38.
  • 39. National Tobacco Control Cell  The NTCC is responsible for overall policy formulation, planning, monitoring and evaluation of the different activities envisaged under the programme. National cell functions Joint Sec/Director and technical support is provided by DGHS( i.e. DDG/CMO.
  • 41.
  • 42. Training: STCC should train multiple stake holders of tobacco control level advocacy workshops/senitization programmes. Efforts should be made to involve all state government department for tobacco control. Specific tailors made trainings should be organised for academicians, Health medical/professionals, students, police, food and drug safety authorities, judiciary, Media etc.
  • 43.
  • 44.
  • 45. NTCP at District Level  Every identified district should have District Tobacco Control Cell (DTCC) in the District Hospital.  The DTCC is headed by DNO preferably CMO/CS on full time basis.  It is desirable that the DNO under NTCP is also given the responsibility to look after the NCD programmes like NPCDCS, NMHP, NPHCE.Other team members of this cell include Psychologist/Counsellor, Social worker and Data Entry Operator on contractual basis under NTCP.
  • 46. Target Trainees:  Doctors, Nurses, Community Health Workers, ASHAs, Civil society Organisations, NCC, IMA, IDA, Teachers, Officials from Enforcement deptt. Like Police, Food Authorities, Municipal Officers etc.
  • 47.
  • 48.
  • 49.  Block Level Interventions: Block level coordination committee; Block chairperson, members of block panchayat and gram pradhans (village Heads), prominenet NGOs, CBOs ,local MLAs,MPs, Incharge MO of the Block PHC as convener. Block level activities; orientation and senitization of representatives, working towards tobacco free schools and offices in block.
  • 50. Village level interventions:  Village Level committee; village Pradhan, ASHA,ANM, Anganwadi worker , the meetings need to be conevened by the ASHA worker.  Village level activities; senitization of village level officials, Gram Panchayat, CBOs like Farmers clubs, Mothers froups, SHGs, Youth/ Adolescent club etc . Special IEC compaign involving school children on World No Tobacco Day, and special days.
  • 51. What Further?  Integration of NTCP with other health interventions/programmes.  As we are very well aware that tobacco is a risk factor for cancer of various organs,CVS and Pulmonary diseases, and is strongly assoiciated with it. Moreover also strong association with pregnacy n consequences.
  • 52. Conclusions  There are numbers of programme for diseases control ,all efforts must be made to integrate NTCP activities into the ongoing National Health programmes like RNTCP, NMHP. NPCB, NPDCS, RCH etc.